|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.39 USD | -5.57% |
|
-4.24% | -40.84% |
Caribou Biosciences, Inc. announced the appointment of David L. Johnson to its board of directors. Johnson is a seasoned executive with 30 years of commercial and operational experience in the biopharmaceutical industry. Johnson currently serves as chief commercial officer of Global Blood Therapeutics.
Previously, Johnson spent 15 years at Gilead Sciences, Inc.
| 1st Jan change | Capi. | |
|---|---|---|
| -40.84% | 306M | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
CARIBOU BIOSCIENCES, INC. 